PuneetSAroraMD

Diabetes, Lipid Metabolism

Chief Medical Officer, Skye Bioscience

Dr. Arora is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
11250 El Camino Real
Suite C
San Diego, CA 92130
Phone+1 858-251-7528

Mayo Graduate SchoolMS, Clinical Research, 2002 - 2005
Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Endocrinology, Diabetes, and Metabolism, 2001 - 2003
NYU Grossman School of MedicineFellowship, Endocrinology, Diabetes, and Metabolism, 1999 - 2001
Southern Illinois UniversityResidency, Internal Medicine, 1996 - 1999
All India Institute of Medical SciencesClass of 1995

PubMed

64 citations
Antibody-mediated activation of the FGFR1/Klothoβ complex corrects metabolic dysfunction and alters food preference in obese humans
Amos Baruch, Chin Wong, Leslie W. Chinn, Anjali Vaze, Junichiro Sonoda
Proceedings of the National Academy of Sciences of the United States of America. 2020-11-17
27 citations
Effects of duration of type 2 diabetes mellitus on insulin secretion.
Farhad Zangeneh, Puneet S. Arora, Peter James Dyck, Lynn M. Bekris, Åke Lernmark
Endocrine Practice. 2006-07-01

Journal Articles

• Rilzabrutinib, an Oral BTK Inhibitor, in Immune Thrombocytopenia
David J. Kuter, M.D., Merlin Efraim, M.D., Jiri Mayer, M.D., Marek Trněný, M.D., Vickie McDonald, M.D., Robert Bird, M.B., B.S., Thomas Regenbogen, M.D., Mamta Garg, M..., NEJM, 4/14/2022